BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 19860735)

  • 1. Structural and computational biology of the molecular chaperone Hsp90: from understanding molecular mechanisms to computer-based inhibitor design.
    Verkhivker GM; Dixit A; Morra G; Colombo G
    Curr Top Med Chem; 2009; 9(15):1369-85. PubMed ID: 19860735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational Modeling of the Hsp90 Interactions with Cochaperones and Small-Molecule Inhibitors.
    Verkhivker GM
    Methods Mol Biol; 2018; 1709():253-273. PubMed ID: 29177665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Role and Hierarchy of the Intermolecular Interactions in Binding of Protein Kinase Clients to the Hsp90-Cdc37 Chaperone: Structure-Based Network Modeling of Allosteric Regulation.
    Stetz G; Verkhivker GM
    J Chem Inf Model; 2018 Feb; 58(2):405-421. PubMed ID: 29432007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Hsp90 chaperone machinery: from structure to drug development.
    Hahn JS
    BMB Rep; 2009 Oct; 42(10):623-30. PubMed ID: 19874705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ensemble-based modeling and rigidity decomposition of allosteric interaction networks and communication pathways in cyclin-dependent kinases: Differentiating kinase clients of the Hsp90-Cdc37 chaperone.
    Stetz G; Tse A; Verkhivker GM
    PLoS One; 2017; 12(11):e0186089. PubMed ID: 29095844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling signal propagation mechanisms and ligand-based conformational dynamics of the Hsp90 molecular chaperone full-length dimer.
    Morra G; Verkhivker G; Colombo G
    PLoS Comput Biol; 2009 Mar; 5(3):e1000323. PubMed ID: 19300478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing molecular mechanisms of the Hsp90 chaperone: biophysical modeling identifies key regulators of functional dynamics.
    Dixit A; Verkhivker GM
    PLoS One; 2012; 7(5):e37605. PubMed ID: 22624053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atomistic simulations and network-based modeling of the Hsp90-Cdc37 chaperone binding with Cdk4 client protein: A mechanism of chaperoning kinase clients by exploiting weak spots of intrinsically dynamic kinase domains.
    Czemeres J; Buse K; Verkhivker GM
    PLoS One; 2017; 12(12):e0190267. PubMed ID: 29267381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric Modulators of HSP90 and HSP70: Dynamics Meets Function through Structure-Based Drug Design.
    Ferraro M; D'Annessa I; Moroni E; Morra G; Paladino A; Rinaldi S; Compostella F; Colombo G
    J Med Chem; 2019 Jan; 62(1):60-87. PubMed ID: 30048133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Hsp90 chaperone machinery: conformational dynamics and regulation by co-chaperones.
    Li J; Soroka J; Buchner J
    Biochim Biophys Acta; 2012 Mar; 1823(3):624-35. PubMed ID: 21951723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer Inhibitors of Hsp90 Function: Beyond the Usual Suspects.
    Garg G; Khandelwal A; Blagg BS
    Adv Cancer Res; 2016; 129():51-88. PubMed ID: 26916001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimentally guided structural modeling and dynamics analysis of Hsp90-p53 interactions: allosteric regulation of the Hsp90 chaperone by a client protein.
    Blacklock K; Verkhivker GM
    J Chem Inf Model; 2013 Nov; 53(11):2962-78. PubMed ID: 24191708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hsp90: Friends, clients and natural foes.
    Verma S; Goyal S; Jamal S; Singh A; Grover A
    Biochimie; 2016 Aug; 127():227-40. PubMed ID: 27295069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational modeling of allosteric regulation in the hsp90 chaperones: a statistical ensemble analysis of protein structure networks and allosteric communications.
    Blacklock K; Verkhivker GM
    PLoS Comput Biol; 2014 Jun; 10(6):e1003679. PubMed ID: 24922508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Hsp90 molecular chaperone: an open and shut case for treatment.
    Pearl LH; Prodromou C; Workman P
    Biochem J; 2008 Mar; 410(3):439-53. PubMed ID: 18290764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and development of heat shock protein 90 inhibitors as anticancer agents: a review of patented potent geldanamycin derivatives.
    Kim T; Keum G; Pae AN
    Expert Opin Ther Pat; 2013 Aug; 23(8):919-43. PubMed ID: 23641970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking the chaperone kinome pathway: mechanistic insights into a novel dual inhibition approach for supra-additive suppression of malignant tumors.
    Grover A; Shandilya A; Agrawal V; Pratik P; Bhasme D; Bisaria VS; Sundar D
    Biochem Biophys Res Commun; 2011 Jan; 404(1):498-503. PubMed ID: 21144839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric Mechanism of the Hsp90 Chaperone Interactions with Cochaperones and Client Proteins by Modulating Communication Spines of Coupled Regulatory Switches: Integrative Atomistic Modeling of Hsp90 Signaling in Dynamic Interaction Networks.
    Astl L; Stetz G; Verkhivker GM
    J Chem Inf Model; 2020 Jul; 60(7):3616-3631. PubMed ID: 32519853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure, function and regulation of the hsp90 machinery.
    Li J; Buchner J
    Biomed J; 2013; 36(3):106-17. PubMed ID: 23806880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of heat shock protein 90 chaperone function through binding of a novobiocin analog KU-32.
    Chatterjee BK; Jayaraj A; Kumar V; Blagg B; Davis RE; Jayaram B; Deep S; Chaudhuri TK
    J Biol Chem; 2019 Apr; 294(16):6450-6467. PubMed ID: 30792306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.